| |
|
|
|
|
|
|
|||
|
Blood, 15 February 2007, Vol. 109, No. 4, pp. 1550-1558. Prepublished online as a Blood First Edition Paper on October 17, 2006; DOI 10.1182/blood-2006-05-024034.
IMMUNOBIOLOGY Kaposi sarcoma herpesvirusencoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells1 Cancer Research United Kingdom Viral Oncology Group, Wolfson Institute for Biomedical Research, University College London, London, United Kingdom; 2 Department of Immunology, Imperial College, London, United Kingdom; and 3 Department of Microbiology and Department of Dermatology, New York University School of Medicine, New York, NY
Kaposi sarcomaassociated herpesvirus (KSHV) is etiologically linked to Kaposi sarcoma (KS), a tumor genetically akin to lymphatic endothelial cells (LECs). We obtained the immune transcriptional signature of KS and used KSHV-infected LECs (KLECs) as an in vitro model to determine the effects of KSHV on transcription and expression of genes involved in immunity. The antigen presentation, interferon (IFN) response, and cytokine transcriptomes of KLECs resemble those of KS. Transcription of genes involved in class I presentation is increased in KS and after infection of LECs, but MHC-I and ICAM-1 surface expression are down-regulated in KLECs. Inhibition of IFN induction of MHC-I transcription indicates that KSHV regulates MHC-I transcription. We show that MHC-I transcription is regulated by the KSHV-encoded viral FLICE inhibitory protein (vFLIP) and by viral IFN regulatory factor 1 (vIRF1). vFLIP up-regulates MHC-I and ICAM-1 through activation of NF-
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||